Kristine A. Frerichs

Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma

Christie P.M. Verkleij, Marloes E.C. Broekmans, Mark van Duin et al. · Blood Advances · 2021 · 163 citations · Full text

Medicine, Immunology, Pharmacology +16

Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence

Afroditi Katsarou, Maria Sjöstrand, Jyoti Naik et al. · Science Translational Medicine · 2021 · 121 citations · Full text

Life Sciences, Cell Biology, Immunology +13

Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab

Kristine A. Frerichs, Marloes E.C. Broekmans, Jhon A. Marin Soto et al. · Clinical Cancer Research · 2020 · 87 citations · Full text

Medicine, Immunology, Pharmacology +17

Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation

Kristine A. Frerichs, Christie P.M. Verkleij, María‐Victoria Mateos et al. · Blood Advances · 2023 · 78 citations · Full text

Life Sciences, Hematology, Immunology +17

T-Cell Characteristics Impact Response and Resistance to T-Cell–Redirecting Bispecific Antibodies in Multiple Myeloma

Christie P.M. Verkleij, Chloe O’Neill, Marloes E.C. Broekmans et al. · Clinical Cancer Research · 2024 · 58 citations · Full text

Life Sciences, Hematology, Immunology +16